BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8555051)

  • 1. Both early and committed haemopoietic progenitors are more frequent in peripheral blood than in bone marrow during mobilization induced by high-dose chemotherapy + G-CSF.
    Tarella C; Benedetti G; Caracciolo D; Castellino C; Cherasco C; Bondesan P; Omedé P; Ruggieri D; Gianni AM; Pileri A
    Br J Haematol; 1995 Nov; 91(3):535-43. PubMed ID: 8555051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors affecting the mobilization of primitive and committed hematopoietic progenitors into the peripheral blood of cancer patients.
    Schneider JG; Crown JP; Wasserheit C; Kritz A; Wong G; Reich L; Norton L; Moore MA
    Bone Marrow Transplant; 1994 Dec; 14(6):877-84. PubMed ID: 7536069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progenitor content of autologous grafts: mobilized bone marrow vs mobilized blood.
    Dahl E; Burroughs J; DeFor T; Verfaillie C; Weisdorf D
    Bone Marrow Transplant; 2003 Sep; 32(6):575-80. PubMed ID: 12953129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological characterization of CD34+ cells mobilized into peripheral blood.
    Lemoli RM; Tafuri A; Fortuna A; Catani L; Rondelli D; Ratta M; Tura S
    Bone Marrow Transplant; 1998 Dec; 22 Suppl 5():S47-50. PubMed ID: 9989890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transplantation potential of hematopoietic cells released into the circulation during routine chemotherapy for non-Hodgkin's lymphoma.
    Pettengell R; Testa NG; Swindell R; Crowther D; Dexter TM
    Blood; 1993 Oct; 82(7):2239-48. PubMed ID: 7691253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of short G-CSF administration on the numbers and clonogenic efficiency of hematopoietic progenitor cells in bone marrow and peripheral blood of normal donors.
    Zaucha JM; Knopińska-Posłuszny W; Bieniaszewska M; Myśliwski A; Hellmann A
    Ann Transplant; 2000; 5(4):20-6. PubMed ID: 11499355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency and differentiation capacity of circulating LTC-IC mobilized by G-CSF or GM-CSF following chemotherapy: a comparison with steady-state bone marrow and peripheral blood.
    Benboubker L; Binet C; Cartron G; Bernard MC; Clement N; Delain M; Degenne M; Desbois I; Colombat P; Domenech J
    Exp Hematol; 2002 Jan; 30(1):74-81. PubMed ID: 11823040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concomitant mobilization of plasma cells and hematopoietic progenitors into peripheral blood of patients with multiple myeloma.
    Lemoli RM; Cavo M; Fortuna A
    J Hematother; 1996 Aug; 5(4):339-49. PubMed ID: 8877709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of marrow and blood haemopoietic progenitors in chronic lymphocytic leukaemia before and after chemotherapy.
    Sala R; Mauro FR; Bellucci R; De Propris MS; Cordone I; Lisci A; Foà R; de Fabritiis P
    Eur J Haematol; 1998 Jul; 61(1):14-20. PubMed ID: 9688287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.
    Gehling UM; Ryder JW; Hogan CJ; Hami L; McNiece I; Franklin W; Williams S; Helm K; King J; Shpall EJ
    Exp Hematol; 1997 Oct; 25(11):1125-39. PubMed ID: 9328449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis for recovery and loss of mononuclear cells and colony-forming units granulocyte-macrophage during ex vivo processing of autologous bone marrow.
    Schwella N; Heuft HG; Rick O; Blasczyk R; Wittmann G; Huhn D
    Vox Sang; 1996; 70(3):132-8. PubMed ID: 8740003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral blood progenitor cell harvesting in multiple myeloma and malignant lymphoma.
    Scott MA; Ager S; Apperley JF; Jestice HK; Bloxham DM; Boraks P; Mahendra P; Marcus RE
    Leuk Lymphoma; 1995 Nov; 19(5-6):479-84. PubMed ID: 8590850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of chemotherapy and GM-CSF on hemopoietic progenitor cell mobilization in multiple myeloma.
    Tarella C; Boccadoro M; Omedé P; Bondesan P; Caracciolo D; Frieri R; Bregni M; Siena S; Gianni AM; Pileri A
    Bone Marrow Transplant; 1993 Apr; 11(4):271-7. PubMed ID: 7683551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primitive multilineage progenitor cells predominate in peripheral blood early after mobilization with high-dose cyclophosphamide and GM-CSF or G-CSF.
    Croockewit S; Raymakers R; Trilsbeek C; Dolstra H; Pennings A; de Witte T
    Leukemia; 1994 Dec; 8(12):2194-9. PubMed ID: 7528861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphologic, immunophenotypic and in vitro growth characteristics of blood and bone marrow associated with stem cell mobilisation in patients with lymphoma.
    Ghielmini M; Marangoni G; Pampallona S; Tamasy P; Cavalli F
    Leuk Lymphoma; 2000 Jul; 38(3-4):351-61. PubMed ID: 10830742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Both cycling and noncycling primitive progenitors continue to be mobilized into the circulation during the leukapheresis of patients pretreated with chemotherapy and G-CSF.
    Ponchio L; Eaves C; Hogge D; Perotti C; Torretta L; Cerani P; Salvaneschi L; Ascari E; Cazzola M
    Br J Haematol; 1997 Nov; 99(2):394-402. PubMed ID: 9375761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating progenitors following high-dose sequential (HDS) chemotherapy with G-CSF: short intervals between drug courses severely impair progenitor mobilization.
    Tarella C; Caracciolo D; Gavarotti P; Bondesan P; Cherasco C; Omedè P; Bregni M; Siena S; Gianni AM; Pileri A
    Bone Marrow Transplant; 1995 Aug; 16(2):223-8. PubMed ID: 7581140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term cultures to evaluate engraftment potential of CD34+ cells from peripheral blood after mobilization by chemotherapy with and without GM-CSF.
    Benboubker L; Domenech J; Linassier C; Desbois I; Delain M; Lamagnere JP; Colombat P; Binet C
    Exp Hematol; 1995 Dec; 23(14):1568-73. PubMed ID: 8542948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined use of growth factors to stimulate the proliferation of hematopoietic progenitor cells after autologous bone marrow transplantation for lymphoma patients.
    Lemoli RM; Fortuna A; Fogli M; Rosti G; Gherlinzoni F; Visani G; Catani L; Gozzetti A; Tura S
    Acta Haematol; 1996; 95(3-4):164-70. PubMed ID: 8677737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.